n(w)-nitroarginine benzyl ester has been researched along with ketamine in 1 studies
| Studies (n(w)-nitroarginine benzyl ester) | Trials (n(w)-nitroarginine benzyl ester) | Recent Studies (post-2010) (n(w)-nitroarginine benzyl ester) | Studies (ketamine) | Trials (ketamine) | Recent Studies (post-2010) (ketamine) |
|---|---|---|---|---|---|
| 12 | 0 | 1 | 15,029 | 2,321 | 6,678 |
| Protein | Taxonomy | n(w)-nitroarginine benzyl ester (IC50) | ketamine (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 4.216 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 4.216 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 5.02 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 5.02 | |
| Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | 3.7762 | |
| Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | 3.5563 | |
| Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | 4.1059 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 5.02 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 5.02 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 5.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anwar, M; Banister, RE; Feng, CJ; Kadowitz, PJ; Kaye, AD; Nossaman, BD | 1 |
1 other study(ies) available for n(w)-nitroarginine benzyl ester and ketamine
| Article | Year |
|---|---|
Pulmonary vasodilation by ketamine is mediated in part by L-type calcium channels.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adamantane; Anesthetics, Dissociative; Animals; Arachidonic Acid; Arginine; Blood Pressure; Calcium Channel Blockers; Calcium Channels; Cromakalim; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Ketamine; Lung; Male; Meclofenamic Acid; Morpholines; Potassium Channels; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Vasodilation; Verapamil | 1998 |